By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


Drug Discovery

Company News
PTC Therapeutics (PTCT) Completes Enrollment Of Phase 3 Clinical Trial Of Translarna For Patients With Cystic Fibrosis 11/19/2015 6:15:58 AM
PTC Therapeutics (PTCT) Reports Third Quarter 2015 Financial Results, Provides Corporate Update And Reviews Key Findings From ACT DMD 11/10/2015 8:13:49 AM
PTC Therapeutics (PTCT) To Participate At Upcoming Investor Conferences 11/4/2015 9:29:53 AM
PTC Therapeutics (PTCT) Announces Launch Of STRIVE Grant Award Program For Cystic Fibrosis 10/29/2015 6:58:10 AM
PTC Therapeutics (PTCT) To Host Conference Call To Discuss Third Quarter 2015 Financial Results 10/28/2015 11:18:56 AM
PTC Therapeutics (PTCT) DMD Drug Fails Trial But Company Says Data is Enough for a FDA Filing 10/16/2015 6:03:07 AM
PTC Therapeutics (PTCT) Release: Phase 2 Data From Spinal Muscular Atrophy Program To Be Presented At The 20th International Annual Congress Of The World Muscle Society 10/5/2015 6:49:45 AM
PTC Therapeutics (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 10/5/2015 6:32:59 AM
PTC Therapeutics (PTCT) Submits European Application For Translarna For Cystic Fibrosis 9/30/2015 7:19:34 AM
Health Canada Initiates Review Of PTC Therapeutics (PTCT)' New Drug Submission For Translarna For The Treatment Of Duchenne Muscular Dystrophy 9/18/2015 8:13:03 AM